© PR Newswire
10.04.2025
ORX
LISTED
STO
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
News Preview
The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields.Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the nose and lungs (IgA).The collaboration is in line with Orexo'...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.04.2025
EVT
LISTED
XETR
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
News Preview
HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April 2025.The Company is going to host a conference call to discuss 2024 results as well as to provide an update on the concluded strategic review proc...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.04.2025
FAGR
LISTED
EURONEXT
Record first-quarter revenue of €239 million, reflecting 14% topline growth
News Preview
...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
10.04.2025
FAGR
LISTED
EURONEXT
Fagron to present its upgraded growth strategy and mid-term financial targets at its Capital Markets Day 2025
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7AM CET...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.04.2025
ICLR
LISTED
NASDAQ
Deadline Soon: ICON plc (ICLR) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and January 13, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
BAVA
LISTED
CPH
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
News Preview
COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results:...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
RXRX
LISTED
NASDAQ
Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries
News Preview
Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced the generation of screening libraries leveraging tools within its AI/ML platform, the Recursion OS, with Enamine's REAL Space, the world’s largest...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
OXB
LISTED
LSE
Preliminary results for the year ended 31 December 2024
News Preview
~ Strong commercial momentum underpins transformative financial performance ~...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
News Preview
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from Phase 2 Extension Period in Ulcerative Colitis on Long-Term Benefits and Safety of Anti-IL-7R mAb Lusvertikimab...
Themefolio
Profiler
Peergroup
© BusinessWire
09.04.2025
ICLR
LISTED
NASDAQ
ICON 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ICON plc - ICLR
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in securities class action lawsuits against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2...
Themefolio
Profiler
Peergroup
© BusinessWire
08.04.2025
AMRX
LISTED
NASDAQ
Amneal to Report First Quarter 2025 Results on May 2, 2025
News Preview
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its first quarter 2025 financial results on Friday, May 2, 2025, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be acc...
Themefolio
Profiler
Peergroup
© PR Newswire
08.04.2025
SECT_B
LISTED
STO
Sectra's fully managed AI offering extended to include pathology following new Amplifier partner agreement
News Preview
LINKÖPING, Sweden, April 8, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be the first AI applications for pathology available via Sectra through a single contract, a single hosting soluti...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
07.04.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – April 7th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.04.2025
IBAB
LISTED
EURONEXT
IBA long-term strategy presented at 2025 Capital Markets Day
News Preview
Announcement of the appointment of Catherine Vandenborre as CFO...
Themefolio
Profiler
Peergroup
© BusinessWire
07.04.2025
AMRX
LISTED
NASDAQ
Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced a new analysis of the pivotal RISE-PD Phase 3 study showed that patients who successfully converted to CREXONT from immediate release (IR) carbidopa/levodopa (CD/LD) experienced statistically significant improvements in slee...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.04.2025
SRT3
LISTED
XETR
Sartorius übernimmt Mikrogewebegeschäft MatTek von schwedischer BICO AB
News Preview
Göttingen | 4. April 2025
Sartorius übernimmt Mikrogewebegeschäft MatTek von schwedischer BICO AB
Akquisition erweitert Sartorius‘ Zellkulturangebot um 3D-Mikrogewebemodelle und Primärzellen
MatTeks Lösungen ergänzen Sartorius-Portfolio für schnellere und effektivere Medikamentenentwicklung, wie zellanalytische Instrumente, Reagenzien und KI-M......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.04.2025
SRT3
LISTED
XETR
Sartorius to acquire microtissue business MatTek from Swedish BICO AB
News Preview
Göttingen, Germany | April 4, 2025
Sartorius to acquire microtissue business MatTek from Swedish BICO AB
Acquisition will advance Sartorius’ cell culture portfolio with 3D microtissue models and primary cells
MatTek’s solutions are highly compatible with Sartorius’ cell analysis instruments, reagents and AI models for faster and more effective......
Themefolio
Profiler
Peergroup
© ActuNews
04.04.2025
OXUR
LISTED
EURONEXT
OXURION : Postponement Annual Shareholders Meeting
News Preview
Leuven, BELGIUM – April 4, 2025 – 02:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding the financial calendar:
Due to administrative reasons, the annual accounts of the Company have not been finalized yet. Hence, the Company has decided...
Themefolio
Profiler
Peergroup
© ActuNews
04.04.2025
OXUR
LISTED
EURONEXT
OXURION : Uitstel Gewone Algemene Vergadering
News Preview
Leuven, BELGIË – 4 april 2025 – 14u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag de volgende aankondiging gedaan met betrekking tot zijn financiële kalender:
Omwille van administratieve redenen werd de jaarrekening van de Vennootschap nog niet ge...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.04.2025
IBAB
LISTED
EURONEXT
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day
News Preview
Louvain-la-Neuve, Belgium, 04 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast....
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
SLP
LISTED
NASDAQ
Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025.
Second Quarter 2025 Financia...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
ICLR
LISTED
NASDAQ
ICLR Deadline: Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024. ICON is a clinical research organization.
For more information, submit a form, email attorney Phillip Kim, or give us a call...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.04.2025
PHARM
LISTED
EURONEXT
First Berlin Equity Research GmbH: Pharming Group NV | Rating: Buy
News Preview
Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
03.04.2025 / 17:08 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude ......
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025
News Preview
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
AMRX
LISTED
NASDAQ
Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that three large insurance coverage accounts, the Veterans Administration (VA), UnitedHealthcare and CVS Health, have added CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
ORNBV
LISTED
HEL
Orion Corporation: Organising meeting of the Board of Directors
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE3 APRIL 2025 at 16.25 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
ORNBV
LISTED
HEL
Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING3 APRIL 2025 at 16.20 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© ActuNews
02.04.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – April 2, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on April 1, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
02.04.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 2 april 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparanti...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.04.2025
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
News Preview
Autolus will present in a fireside chat at the Needham Healthcare Conference on Wednesday, April 9, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
02.04.2025
IMMNOV
LISTED
STO
Immunovia publishes the Annual Report for 2024
News Preview
LUND, Sweden, April 2, 2025 /PRNewswire/ -- Immunovia AB (publ) today announced that the Annual Report for 2024 has been published.
The annual report can be downloaded in pdf format and is available on Immunovia's website.
For more information, please contact:
Jeff Borcherding CEO and President jeff.borcherding@immunovia.com
Immunovia in brie...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.04.2025
IBAB
LISTED
EURONEXT
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan
News Preview
Louvain-La-Neuve, Belgium, April 2nd, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be located...
Themefolio
Profiler
Peergroup
© BusinessWire
01.04.2025
AMRX
LISTED
NASDAQ
Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) today announced the U.S. launch of BORUZU™, a new presentation of bortezomib for ready-to-use subcutaneous administration or intravenous (IV) administration. This new ready-to-use oncology product redu...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
BIOA B
LISTED
STO
The European Commission refers lecanemab decision to Appeal Committee
News Preview
STOCKHOLM, April 1, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission (EC) has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.
The final process for the EC decision on lecanemab's Marketing Authorisation A...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
BIOA B
LISTED
STO
The European Commission refers lecanemab decision to Appeal Committee
News Preview
STOCKHOLM, April 1, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission (EC) has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.
The final process for the EC decision on lecanemab's Marketing Authorisation A...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
CELC
LISTED
NASDAQ
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
News Preview
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following inve...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
News Preview
Autolus will host an R&D investor event on Wednesday, April 23, 2025 at 8:30am EDT....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition appoints new CEO
News Preview
STOCKHOLM, SWEDEN – April 1, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) annouces that Viktor Drvota today takes over as CEO of the portfolio company Umecrine Cognition. Viktor Drvota remains the CEO of Karolinska Development....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
POAI
LISTED
NASDAQ
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
News Preview
Company continues to progress toward the signing of a definitive merger agreement with Renovaro Company continues to progress toward the signing of a definitive merger agreement with Renovaro...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
SOBI
LISTED
STO
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
News Preview
STOCKHOLM, April 1, 2025 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Thursday, 8 May 2025 at 10.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
The Board of Directors has decided that sharehol...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
IMMNOV
LISTED
STO
The exercise period for warrants series TO 3 begins today
News Preview
LUND, Sweden, April 1, 2025 /PRNewswire/ -- Today, 1 April 2025, the exercise period for warrants series TO 3 in Immunovia AB (publ) ("Immunovia" or the "Company") (the "Warrant Programme") begins. The exercise period runs until 15 April 2025.
Summarized terms for the warrants of series TO 3
Structure: One (1) warrant series TO 3 entitles the ho...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
SOBI
LISTED
STO
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
News Preview
STOCKHOLM, April 1, 2025 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Thursday, 8 May 2025 at 10.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
The Board of Directors has decided that sharehol...
Themefolio
Profiler
Peergroup
© Newsfile
01.04.2025
COPN
LISTED
SIX
Cosmo Appoints Federico Sommariva as Chief Legal Counsel
News Preview
Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced the appointment of Federico Sommariva ad Chief Legal Counsel. Federico reports to the CEO and is member of the management team. Federico Sommariva has many years of legal and management...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition presents promising preclinical Parkinson data at AD/PD 2025
News Preview
STOCKHOLM, SWEDEN – April 1, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition presents recent preclinical data showing that golexanolone reverses dopamine loss and sustains improvements of Parkinsonian symptoms at the 19th International Conference on Alzheimer’s and Parkinson’s D...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
ATNM
LISTED
XASE
Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE American: ATNM) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LO...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – March 31st, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
GMAB
LISTED
CPH
TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
CYRX
LISTED
NASDAQ
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
News Preview
DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics.DHL and Cryoport form stra...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
SOBI
LISTED
STO
Sobi publishes Annual and sustainability report for 2024
News Preview
STOCKHOLM, March 31, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) published its Annual and sustainability report today. The report details the progress Sobi has made in 2024 and how Sobi strives to identify and unlock potential breakthrough innovations that transform the lives of people with rare diseases.
Sobi has a strong f...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
ATNM
LISTED
XASE
Actinium Pharmaceuticals, Inc. (ATNM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE American: ATNM) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ACTINIUM PHARMACEUTICALS, INC. (ATNM), CONTACT THE LAW OFFICES OF...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
SOBI
LISTED
STO
Sobi publishes Annual and sustainability report for 2024
News Preview
STOCKHOLM, March 31, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) published its Annual and sustainability report today. The report details the progress Sobi has made in 2024 and how Sobi strives to identify and unlock potential breakthrough innovations that transform the lives of people with rare diseases.
Sobi has a strong f...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
VITR
LISTED
STO
The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation
News Preview
GOTHENBURG, Sweden, March 31, 2025 /PRNewswire/ -- To further drive the execution of the Vitrolife Group corporate strategy, the company is evolving the executive management team and introducing a SVP Innovation role to accelerate the pace and output of innovation.
Rickard Ericsson, formerly SVP Consumables and prior to that SVP Sales & Mar...
Themefolio
Profiler
Peergroup
© EQS Newswire
31.03.2025
SRT3
LISTED
XETR
First ISCC Plus certifications pave the way for renewable plastics at Sartorius
News Preview
Göttingen, Germany | March 31, 2025
First ISCC Plus certifications pave the way for renewable plastics at Sartorius
ISCC Plus certification for plants in Aubagne (France) and Stonehouse (UK)
Production with bio-circular feedstock has started
Additional sites in Germany and Finland to follow
The life science group Sartorius has earned its fir......
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
CYRX
LISTED
NASDAQ
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
News Preview
NASHVILLE, Tenn., March 31, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced that the Company will host an investor call today, Monday, March 31, 2025, at 8:30 a.m. ET, to discuss the Company's recent strategic agreement and tr...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
TRAW
LISTED
NASDAQ
Traws Pharma Reports Full Year 2024 Results and Business Highlights
News Preview
Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules First Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025 after the market closes on Wednesday, April 30, 2025. The company will hold a conference call and webcast to discuss its financial results and performance...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
GMAB
LISTED
CPH
Transactions in connection with share buy-back program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
CTEC
LISTED
LSE
Convatec Announces Exclusive Collaboration With Largest Wound, Ostomy and Continence Professional Nursing Organisation
News Preview
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
